Daily Sepsis Research Analysis
Analyzed 80 papers and selected 3 impactful papers.
Summary
Three impactful studies on sepsis this cycle: a genomic epidemiology investigation in a Botswana neonatal unit traced a large Klebsiella pneumoniae outbreak to multi-use IV fluid bags and showed that MDR-only colonization screening can miss outbreak-prone susceptible clones. A very large UK Biobank cohort linked the triglyceride–glucose (TyG) index to incident sepsis and sepsis mortality in diabetes. An ED-based multicenter registry associated earlier hydrocortisone use in septic shock with lower 28-day mortality, especially in vasopressin-treated patients.
Research Themes
- Genomic epidemiology guiding infection prevention and control in neonatal sepsis
- Early corticosteroid timing and dosing in ED septic shock care
- Metabolic risk stratification for sepsis using the TyG index in diabetes
Selected Articles
1. Integrated epidemiologic investigation and genomic confirmation of a Klebsiella pneumoniae neonatal sepsis outbreak in Botswana.
In a 12‑month neonatal unit surveillance, integration of colonization screening, real-time epidemiology, and WGS traced a large K. pneumoniae BSI outbreak (41 BSIs, 10 deaths) to multi-use IV fluid bags; implementing a 24‑hour discard policy controlled the outbreak. Over half of BSI genomes and all IV fluid isolates were ST1414 and closely related (<25 SNPs). The outbreak clone was third‑generation cephalosporin‑susceptible, escaping MDR-focused colonization surveillance.
Impact: This study shows how WGS integrated with prospective surveillance can identify hidden transmission routes and immediately inform effective IPC policy. It also reveals that MDR-only screening misses outbreak-prone susceptible clones.
Clinical Implications: Adopt integrated WGS-informed outbreak investigations and broaden colonization surveillance beyond MDR organisms in neonatal units. Enforce time‑limited (e.g., 24‑hour) discard policies for multi-use IV medications to prevent cross-transmission.
Key Findings
- Identified 55 K. pneumoniae BSIs over 12 months; a major outbreak included 41 BSIs with 10 deaths.
- WGS linked over half of BSI genomes and all six IV fluid isolates to ST1414 with <25 SNP differences.
- The outbreak clone was third-generation cephalosporin-susceptible and evaded MDR-focused colonization screening.
- Implementing a 24-hour discard policy for IV medications controlled the outbreak.
Methodological Strengths
- Prospective unit-wide surveillance integrated with real-time epidemiology and WGS.
- Robust genomic analyses (MLST, pangenome/reference-based SNPs, Bayesian phylogenetics) to confirm transmission.
Limitations
- Single-center design may limit generalizability to other settings.
- Colonization screening targeted MDR-Kpn; drug-susceptible strains were not captured systematically.
- Only available isolates (n=270) were sequenced, introducing potential selection bias.
Future Directions: Scale integrated WGS-epidemiologic IPC programs across neonatal networks; expand colonization surveillance panels beyond MDR; evaluate cost-effectiveness and rapid WGS turnaround in outbreak control.
Klebsiella pneumoniae (Kpn) is a major cause of infant mortality worldwide, with most transmission occurring among hospitalized neonates in low- and middle-income countries where infections caused by multidrug-resistant Kpn (MDR-Kpn) are increasingly common. We hypothesized that integrating laboratory surveillance for neonatal colonization and infection, real-time epidemiologic investigations, and whole-genome sequencing (WGS) could identify transmission pathways to guide targeted infection preven
2. Association of TyG index with sepsis incidence and mortality: a prospective study with diabetes stratification.
Among 428,207 UK Biobank participants followed for a median 13.04 years, each 1‑unit increase in TyG was associated with higher sepsis incidence (HR 1.18, 95% CI 1.10–1.27) and sepsis mortality (HR 1.16, 95% CI 1.05–1.27) in individuals with diabetes, but not in non‑diabetics (U‑shaped association, non‑significant). Adding TyG improved predictive performance for both outcomes in diabetes.
Impact: This very large, stratified prospective cohort links an easily calculated metabolic marker to sepsis risk in diabetes, supporting risk-informed prevention strategies.
Clinical Implications: In patients with diabetes, consider incorporating TyG into routine risk stratification for sepsis and targeting high‑TyG individuals for intensified infection prevention (vaccinations, foot/skin care, early infection triage) and metabolic optimization.
Key Findings
- Prospective analysis of 428,207 adults (median follow-up 13.04 years) documented 12,410 sepsis events and 6,291 sepsis-related deaths.
- In diabetes, each 1-unit increase in TyG predicted higher sepsis incidence (HR 1.18) and sepsis mortality (HR 1.16) after multivariable adjustment.
- No significant associations in non-diabetics; a U-shaped pattern was observed.
- Adding TyG improved predictive performance for sepsis outcomes among individuals with diabetes.
Methodological Strengths
- Very large, prospective cohort with long follow-up and diabetes stratification.
- Robust multivariable Cox models with evaluation of predictive performance improvement.
Limitations
- Observational design with potential residual confounding and misclassification of sepsis.
- UK Biobank selection may limit generalizability; external validation is needed.
- Clinical actionability thresholds for TyG were not established.
Future Directions: Externally validate TyG-based sepsis risk models in diabetic populations and test whether TyG-lowering interventions reduce sepsis risk.
BACKGROUND: The triglyceride-glucose (TyG) index, a validated surrogate marker of insulin resistance, has been widely investigated for its associations with cardiovascular outcomes in both diabetic and non-diabetic populations. However, its potential role in sepsis development remains largely unexplored. Moreover, whether the relationship between the TyG index and sepsis risk differs according to diabetes status has not been systematically examined. METHODS AND RESULTS: In this prospective cohort
3. Steroid administration, timing, and dose in patients with septic shock in the emergency department: retrospective analysis of a multicenter prospective cohort study.
In 5,127 ED septic shock patients, steroid use (primarily hydrocortisone) was associated with lower 28‑day mortality after extensive adjustment (aOR ~0.75), with a significant benefit in the vasopressin subgroup. Delays from first vasopressor initiation to first hydrocortisone dose and hydrocortisone >300 mg/day were associated with increased mortality.
Impact: Findings address the ED treatment window for septic shock and suggest time-sensitive, dose-conscious hydrocortisone use may improve outcomes, complementing ICU-focused evidence.
Clinical Implications: Consider early hydrocortisone in ED septic shock patients with vasopressor‑refractory hypotension, avoid >300 mg/day dosing, and minimize delays from vasopressor start to steroid initiation while awaiting confirmatory RCTs.
Key Findings
- Steroid therapy (hydrocortisone) associated with lower 28-day mortality (aOR ~0.75) after multiple adjusted analyses (PSM, IPTW, time-dependent Cox).
- Benefit evident in patients receiving vasopressin (aOR 0.631), but not in those without vasopressin (interaction p=0.025).
- Longer interval from first vasopressor initiation to first hydrocortisone dose and hydrocortisone >300 mg/day independently associated with higher mortality.
Methodological Strengths
- Large multicenter ED-based registry with comprehensive statistical adjustments (PSM, IPTW, time-dependent Cox).
- Dose–timing analyses within hydrocortisone-treated subgroup.
Limitations
- Observational design susceptible to residual confounding and indication bias.
- Practice patterns specific to Korean EDs may limit generalizability; no randomization.
- Unmeasured factors (e.g., steroid responsiveness, infection source control timing) may influence outcomes.
Future Directions: Conduct pragmatic ED-based RCTs to test early hydrocortisone strategies (dose and timing), especially in vasopressin-treated shock, with patient-centered outcomes.
The benefit and optimal timing of corticosteroids in septic shock remain debated. Most evidence comes from intensive care unit-based studies, although key treatment decisions are often made early in the emergency department (ED). This study evaluated the association between steroid administration, including hydrocortisone timing and dose, and mortality in patients with septic shock in the ED. This retrospective observational study used an ED-based prospective multicenter septic shock registry from